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doi:10.1Objective: This study investigates the impact of diabetes on myocardium in the setting of acute ischemia–
reperfusion in a porcine model.
Methods: In normoglycemic (ND group) and alloxan-induced diabetic (DM group) male Yucatan pigs, the left
anterior descending coronary artery territory was made ischemic and then reperfused. Hemodynamic values and
myocardial function were measured. Monastryl blue and triphenyl tetrazolium chloride staining were used to as-
sess size of the areas at risk and infarction. Glycogen content was assessed using periodic acid–Schiff staining.
Cell death and survival signaling pathways were assessed by immunoblotting.
Results: Mean arterial pressure and developed left ventricular pressure were lower in the DM group (P< .05).
Whereas global left ventricular function was worse in the DM group (P<.05), regional function in the area at risk
was improved on the horizontal axis (P< .05). Mean infarct size was smaller in the DM versus the ND group
(19% vs 43%; P< .05), whereas the area at risk was similar in both groups (34% vs 36%; P ¼ .7). Ischemic
myocardium in the DM group displayed more prominent staining for glycogen compared with the ND group.
In the area at risk, expression of cell survival proteins including phosphorylated endothelial nitric oxide synthase
(0.17  0.04 vs 0.04  0.01; P<.05), heat shock protein 27 (0.7  0.2 vs 0.3  0.1; P<.05), nuclear factor-kB
(0.14  0.02 vs 0.03  0.01; P<.05), and mammalian target of rapamycin (0.35  0.05 vs 0.15  0.02; P<.05)
were higher in DM animals, whereas in nonischemic tissue, expression of these proteins was similar or lower in
the DM group.
Conclusions: Although type I diabetes worsens global left ventricular function, it is protective in the ischemic
area, leading to increased expression of cell survival proteins and decreased infarct size. (J Thorac Cardiovasc
Surg 2010;140:1345-52)P
MIn the United States, more than 400,000 deaths per year are
attributed to acute myocardial infarction (AMI).1 Current
treatment of AMI is based on rapid restoration of blood
flow to the ischemic area. Unfortunately, this results in addi-
tional reperfusion injury to the myocardium via an induced
inflammatory response and the release of damaging free
radicals.2,3 When added to the initial ischemic insult,
reperfusion injury increases the incidence of a number of
complications, including cardiac dysrhythmias,4 myocardial
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The Journal of Thoracic and Carmia–reperfusion (I–R) injury results in a combination of ne-
crosis, apoptosis, and autophagy of cardiac myocytes, the
severity and onset of which can be modulated by manipula-
tion of certain biochemical pathways via preconditioning and
postconditioning.7 However, the mechanisms by which these
pathways protect myocytes are incompletely understood.
On the other hand, it is widely known that diabetes mel-
litus is associated with increased incidence of multivessel
coronary artery disease, congestive heart failure, and
AMI. Both patients with type 1 and those with type 2 diabe-
tes have significantly poorer clinical outcomes after
AMI, with higher rates of repeat intervention, residual ven-
tricular dysfunction, and overall mortality.8,9 Surprisingly,
experimental studies looking at the sensitivity of the
diabetic heart to ischemic injury have been divided, with
studies showing both injurious and cardioprotective effects
of diabetes.10 The majority of these studies, however, used
either small animal models or in vitro models that do not ad-
equately represent the biochemical and metabolic context
that would be seen in patients with acute ischemia. In this
study, we used a clinically relevant swine model of type I
diabetes to explore the sensitivity of the diabetic heart to
I–R injury in vivo. We found that type I diabetes is cardio-
protective against the insult of acute I–R injury and that
hyperglycemia may actually be beneficial to the heart in
this setting.diovascular Surgery c Volume 140, Number 6 1345
Abbreviations and Acronyms
AAR ¼ area at risk
AMI ¼ acute myocardial infarction
AMPK ¼ adenosine monophosphage–
activated protein kinase
dP/dt ¼ positive first derivative of left
ventricular pressure
4EBP1 ¼ 4E-binding protein 1
Erk ¼ extracellularly regulated kinase
HSP ¼ heat shock protein
I–R ¼ ischemia–reperfusion
LAD ¼ left anterior descending coronary
artery
LV ¼ left ventricular
mTOR ¼ mammalian target of rapamycin
NF-kB ¼ nuclear factor–kB
PDK1 ¼ pyruvate dehydrogenase kinase 1
phospho-
eNOS
¼ phosphorylated endothelial nitric
oxide synthase
SAPK/
JNK
¼ stress-activated protein kinase/c-Jun
NH2-terminal kinase
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MMATERIALS AND METHODS
Experimental Design
Sixteen intact male Yucatan mini-swine were divided into 2 groups: non-
diabetic (ND, n¼ 8) and diabetic (DM, n¼ 8). All animals were fed normal
chow (S11 Purina, St Louis, Mo). Diabetes was induced in DM animals by
a single intravenous injection of alloxan (200 mg/kg) at age 15 weeks (Sin-
clair Research Center, Inc, Columbia, Mo). Alloxan-treated animals that
maintained blood glucose levels greater than 250 mg/dL were used in the
DM group. At 20 weeks of age (5 weeks of exposure to diabetes), animals
were subjected to acute ischemia by occluding the left anterior descending
coronary artery (LAD) for 60 minutes, followed by release of the LAD and
reperfusion for 120 minutes. Hemodynamic and functional measurements
were taken at baseline and for every 30 minutes thereafter. Myocardial seg-
mental shortening in the longitudinal axis (parallel to the LAD) and horizon-
tal axis (perpendicular to the LAD) were recorded as well. At the completion
of the protocol, the heart was excised, and tissue samples were collected for
molecular analyses as described below.
Animals
Swine were housed individually and provided with normal chow and wa-
ter ad libitum. All experiments were approved by the Beth Israel Deaconess
Medical Center Institutional Animal Care and Use Committee and con-
formed to the US National Institutes of Health guidelines regulating the
care and use of laboratory animals (NIH publication No. 5377-3, 1996).
Surgical Protocol
Swine at age 20 weeks were sedated with tiletamine/zolazepam (Tela-
zol; 1.5 mg/kg, intramuscular) and weighed before endotracheal intubation
and ventilation with a volume-cycled ventilator (North American Drager,
Telford, Pa). Anesthesia was maintained with 2.0% isoflurane (Abbott
Laboratories, Inc, North Chicago, Ill). A 5F arterial sheath was passed
into the right femoral artery via direct cutdown and used for arterial blood
sampling and arterial blood pressure monitoring. Arterial blood gas,
hematocrit, and core temperature were measured at the start of surgery1346 The Journal of Thoracic and Cardiovascular Surand every 30 minutes thereafter. Each animal received a 1-L bolus of
lactated Ringer solution followed by continuous infusion (15 mL $ kg1
$ h1). A phenylephrine drip (0.25 mg $ kg1 $ min1) to prevent
isoflurane-induced hypotension, heparin (80 units/kg bolus), and lidocaine
(1.5 mg/kg bolus) to prevent ventricular dysrhythmia were administered.
A median sternotomy was performed. A catheter-tipped manometer
(Millar Instruments, Inc, Houston, Tex) was introduced through the
apex of the heart to record left ventricular (LV) pressure. Segmental short-
ening in the ischemic area at risk (AAR) was assessed with a digital ultra-
sonic crystal measurement system (Sonometrics Corp, London, Ontario,
Canada) using four 2-mm digital ultrasonic probes implanted in the sube-
picardial layer approximately 10 mm apart within the AAR. Cardiosoft
software (Sonometrics Corp) was used for functional measurements.
LAD flow was monitored by a Doppler probe (Transonic Systems, Inc,
Ithaca, NY). The LAD was occluded 3 mm distal to the origin of the sec-
ond diagonal branch by a Rommel tourniquet. After 60 minutes, the tour-
niquet was released and the myocardium allowed to reperfuse for 120
minutes. The LAD was then religated, the ascending aorta was cross-
clamped, and monastryl blue pigment (Engelhard Corp, Louisville, Ky)
was injected into the aortic root to demarcate the AAR. The heart was ex-
cised and sectioned into three 1 cm–thick slices perpendicular to the LAD
from the apex to the point of ligation. Tissue from the slice 1 cm proximal
to the apex was used in molecular studies. The remaining tissue was incu-
bated in 1% triphenyl tetrazolium chloride [(TTC; Sigma Chemical Co,
St. Louis, Mo] solution for 30 minutes and infarct size was assessed as de-
scribed below. Ventricular fibrillation or ventricular tachycardia events
were treated with an extra dose of lidocaine (1.5 mg/kg) and electrical
cardioversion with 20 to 50 J for persistent dysrhythmias.Measurement of Global and Regional Myocardial
Function
Indices of global and regional myocardial function were monitored dur-
ing the entire experiment: mean arterial pressure, developed LV pressure,
positive first derivative of LV pressure (dP/dt), and longitudinal and hori-
zontal segmental shortening in the AAR. These indices were recorded for
10 sequential beats, at baseline, and then every 30 minutes thereafter using
the Sonometrics Cardiosoft system as previously described.11Quantification of Myocardial Infarct Size
The LV (including septum) was isolated, cut into 1-cm slices, and imme-
diately immersed in 1% triphenyl tetrazolium chloride in phosphate-
buffered saline (Boston Bioproducts, Worcester, Mass) at 38C for 30 min-
utes. The infarct area (characterized by absence of staining), noninfarcted
AAR (characterized by bright red tissue staining), and the nonischemic ven-
tricle (characterized by purple tissue staining) were photographed and mea-
sured. AAR as a percentage of total LV surface area and percent infarction
in the AAR was calculated in each individual slice by planimetry (Image J
1.4) using the following equations:
AAR size ¼ ðAAR surface area=LV total surface areaÞ3100
Infarct size ¼ ðLV infarct surface area=LV AAR surface areaÞ3100
Glycogen Staining
Sections of ischemic and nonischemic myocardium from ND (n¼ 5) and
DM (n ¼ 7) animals were placed immediately into 10% formalin and sub-
jected to periodic acid–Schiff staining to assess glycogen content, with
amylase-treated sections serving as negative controls. Ischemic areas were
evaluated for amount of glycogen by a pathologist in a blinded fashion
and were assigned a score from 0 to 5, with 0 representing complete absence
of glycogen and 5 representing strongest staining for glycogen (nonische-
mic myocardium).gery c December 2010
Chu et al Perioperative ManagementWestern Blotting
Myocardial samples were homogenized in RIPA buffer (Boston Bio-
Products, Inc, Worcester, Mass) and total protein concentration determined
by bicinchoninic acid assay (BCA assay; Pierce, Rockford, Ill). Equal
amounts of protein (40 mg) were subjected to sodium dodecyl sulfate poly-
acrylamide gel electrophoresis and immunoblotting as previously de-
scribed.11 Primary antibodies were used according to the manufacturer’s
recommendation. Levels of Akt, phospho-Akt (Thr308), phospho-Akt
(Ser473), phosphorylated endothelial nitric oxide synthase (Ser1177) (phos-
pho-eNOS), extracellularly regulated kinase (Erk) 1/2, phospho-Erk 1/2
(Thr202/Tyr204)), mammalian target of rapamycin (mTOR), phospho-
mTOR (Ser2448), stress-activated protein kinase/c-Jun NH2-terminal ki-
nase (SAPK/JNK), p70S6K1, phospho-p70S6K1 (Thr389), 4E-binding
protein 1 (4EBP1), and phospho-4EBP1 (Thr37/46), nuclear factor–kB
(NF-kB) p65 and (NF-phospho-NF-kB p65 (Ser536), pyruvate dehydroge-
nase kinase 1 (PDK1), and phospho-PDK1 (Ser241) (Cell Signaling Tech-
nology, Beverly, Mass), heat shock protein 27 (HSP27), and HSP70
(Stressgen, Ann Arbor, Mich) were assessed. Myocardial samples from
the nonischemic and the ischemic territories were assessed separately. Vin-
culin was used to confirm equal protein loading, and band intensities were
normalized to Ponceau staining (Sigma Chemical Co).
Statistical Analysis
Clinical, hemodynamic, and global and regional LV functional data were
analyzed using 2-way repeated-measures analysis of variance (Systat, San
Jose, Calif). Post hoc multiple comparison Student–Newman–Keuls test
was applied. Myocardial infarct size, glycogen staining, and Western blot
densitometry were analyzed by the unpaired Student t test. Western blot
data are presented as density in arbitrary units. Data are reported as
mean  standard error of the mean.P
MRESULTS
Diabetic Swine
There was a significant difference in animal weight be-
tween ND and DM animals (ND 22.2  1 kg vs DM 17 
1 kg; P¼ .004). The average blood glucose level was signif-
icantly higher in the DM group versus the ND group (309 
57 mg/dL vs 37  10 mg/dL; P< .01). There were no sig-
nificant differences between groups with respect to arterial
blood gas measurements, hematocrit, and core temperature
at any time.Myocardial Infarct Size
The size of the AAR was not significantly different be-
tween groups (34% in DM vs 36% in ND; P ¼ .7;
Figure 1, A), whereas the size of the infarct area was smaller
in the DM group as compared with the ND group (19% in
DM vs 43% in ND; P< .05; Figure 1, B).Hemodynamic Parameters
Before LAD occlusion, the heart rate (P<.01) and devel-
oped LV pressure (P< .01 were lower in the DM group as
compared with the ND group, whereas mean arterial pres-
sure was slightly higher (P ¼ .3). After occlusion, all 3 he-
modynamic parameters were lower in the DM group. LAD
blood flow during the reperfusion period was lower in the
DM group (P< .05; Figure 2).The Journal of Thoracic and CarGlobal and Regional Myocardial Function
Global systolic LV function as determined fromþdP/dt
was significantly worse in the DM group as compared
with the ND group at all times (P< .01; Figure 2, E). Re-
gional LV function as assessed by percent segmental short-
ening on the horizontal axis was significantly better in the
DM group as compared with the ND group (Figure 2, F;
P< .05), whereas function on the longitudinal axis was
not significantly different between groups (not shown).Glycogen Staining
In the AAR, glycogen content was higher in the DM
group compared with the ND group (1.36  0.14 vs
0.70  0.20; P ¼ .02; Figure 3).Protein Expression in the Nonischemic Territory
Cell survival signaling. The expression of total Akt was
higher (P< .01) in the ND group as compared with the
DM group, whereas the expression of phospho-Akt
(Ser473) and phospho-Akt (Thr308) was similar between
groups (not shown). The ratio of phospho-Akt (Thr 308)
to total Akt was significantly higher (P< .01) in the DM
group compared with the ND group (Figure 4, A). The ex-
pression of PDK1 was lower (P< .01) in the DM group
as compared with the ND group (Figure 4, B), whereas the
expression of phospho-PDK1 was similar between groups
(ND 0.1  0.01, DM 0.09  0.01; P ¼ .1). The expression
of HSP27 was similar (P¼ .3) between groups (Figure 4,C),
as was the expression of HSP70 (P ¼ .6; Figure 4, D).
The expression of phospho-eNOS (Ser1177) tended to be
lower in the DM group as compared with the ND group
(Figure 4, E).
The expression of mTOR, phospho-NF-kB p65 (Figure 4,
F), phospho-mTOR (Ser2448) (Figure 4, G), phospho-4E-
BP1 (Thr37/46) (Figure 4, I), NF-kB p65, p70S6K, and
4E-BP1 (not shown), was similar between the groups.
Phospho-p70S6K (Thr389) and phospho-NF-kB p65
(Ser536) were not detected in either group.
Mitogen-activated protein kinase signaling. The expres-
sion of total Erk 1/2 was similar (P¼ .9) between the groups,
whereas the expression of phospho-Erk 1/2 (Thr202/
Tyr204) was lower in the DM group as compared with the
ND group (DM 0.03  0.01, ND 0.07  0.02; P ¼ .04).
The expression of phospho-p90RSK (Ser308) was similar
(P ¼ .4) between the 2 groups (Figure 5, B). The expression
of SAPK/JNK was lower (P ¼ .03) in the DM group
(Figure 5, C).Protein Expression in the AAR
Cell survival signaling. The expression of total Akt and
phospho-Akt (Ser473), and phospho-Akt (Ser 473) was sim-
ilar between the 2 groups (not shown), whereas the ratio of
phospho-Akt (Thr308) to total Akt tended to be higher in thediovascular Surgery c Volume 140, Number 6 1347
FIGURE 1. Size of AAR as a percentage of LV surface area (P ¼ .7, A) and necrotic area as a percentage of AAR (B) in ND and DM animals. Shown are
representative slices of ND (C) and DM (D) ventricle, with purple arrows pointing to nonischemic area, red arrows to AAR, and gray arrows to infarct area.
Data presented as mean  SEM comparing ND (n ¼ 8) and DM (n ¼ 8) groups. *P< .05. AAR, Area at risk; LV, left ventricular; ND, nondiabetic; DM,
diabetic.
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MDM group as compared with the ND group (Figure 4, A).
The expression of PDK1 (P < .01; Figure 4, B) and
phospho-PDK1 (Ser241) (DM 0.2  0.01, ND 0.08 
0.02; P< .01) was higher in the DM group. The expression
of HSP27 and HSP70 was higher (P<.05) in the DM group,
as shown in Figure 4, C and D. The expression of phospho-
eNOS (Ser1177) was higher (P< .01) in the DM group
(Figure 4, E). The expression of mTOR (DM 0.035 
0.005, ND 0.017  0.002; P< .01) and phospho-mTOR
(Ser2448) (Figure 4, G) was higher in the DM group. The
expressions of p70S6K (DM 0.09  0.01, ND 0.05 
0.02; P< .01) and phospho-p70S6K (Thr389) (P< .02;
Figure 4, H) were higher in the DM group. The expression
of phospho-4E-BP1 (Thr37/46) was higher (P< .01) in
the DM group (Figure 4, I), whereas the expression of
phospho-4E-BP1 tended to be higher (DM 0.3  0.01, ND
0.2  0.02; P ¼ .07) in the same group. The expression of1348 The Journal of Thoracic and Cardiovascular SurNF-kB p65 (DM 0.14  0.02, ND 0.03  0.01; P< .01)
and phospho-NF-kB p65 (Ser536) (Figure 4, F) was also
higher in the DM group.
Mitogen-activated protein kinase signaling. Total Erk 1/
2 was more highly expressed in ND animals than DM ani-
mals (ND 0.09  0.01, DM 0.04  0.01; P ¼ .01), but the
ratio of phospho-Erk 1/2 (Thr202/Tyr204) expression to to-
tal Erk 1/2 was higher (P ¼ .01) in the DM group (Figure 5,
A). The expression of phospho-p90RSK (Ser308) was
higher (P¼ .01) in the DM group (Figure 5, B). The expres-
sion of SAPK/JNK was also higher (P< .05) in the DM
group (Figure 5, C).
DISCUSSION
In this study, we examined the effects of type 1 diabetes
on LV I–R injury. We11 previously reported that I–R injury
is increased in a porcine hypercholesterolemic model andgery c December 2010
FIGURE 2. Hemodynamic and functional data. Heart rate (A), developed left ventricular pressure (DLVP, B), mean arterial pressure (MAP, C), left anterior
descending (LAD) artery blood flow (D), first derivative of LV pressure over time (þdP/dt, E), and horizontal segmental shortening (SS) axis (F).
Pre ¼ baseline, O1 ¼ 30 minutes occlusion, O2 ¼ 60 minutes occlusion, R1 ¼ 30 minutes reperfusion, R2 ¼ 60 minutes reperfusion, R3 ¼ 90 minutes
reperfusion, R4 ¼ 120 minutes reperfusion. Data presented as mean  SEM comparing ND (n ¼ 8) and DM (n ¼ 8) groups. yP< .05.
Chu et al Perioperative Managementsuspected that similar findings would be evident in our type
1 diabetic model. To our surprise, this study demonstrates
that experimental type I diabetes is cardioprotective against
acute I–R injury, limiting infarct size, improving regional
function, and increasing expression of cell survival mole-FIGURE 3. Glycogen staining using period acid–Schiff stain in nonischemic
arrows indicating intracellular glycogen. Sections shown are representative of a
a blinded fashion and glycogen content was compared (D). Data presented as m
The Journal of Thoracic and Carcules by at-risk myocytes in a porcine model of myocardial
infarction.
It is widely documented that patients with type 1 diabetes
have worse outcomes after coronary artery bypass grafting
than do nondiabetic patients. However, several studiesDM (A), ischemic DM (B), and ischemic ND (C) myocardium, with black
ll sections assessed. DM (n ¼ 7) and ND (n ¼ 5) sections were scored in
ean  SEM in arbitrary units. P ¼ .02. DM, Diabetic; ND, nondiabetic.
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FIGURE 4. Selected cell-survival protein immunblotting results. Ratio of phospho-Akt to total Akt (A), PDK1 (B), HSP27 (C), HSP70 (D), phospho-eNOS
(E), phospho-NF-kB (F), phospho-mTOR (G), phospho-p70S6K (H), and phospho-4E-BP1 (I) expression was assessed in the ischemic and nonischemic
territories of ND (n ¼ 8) and DM (n ¼ 8) animals. Representative bands are shown, with density expressed as arbitrary units. Data presented as mean 
SEM in arbitrary units (AU). *P< .05. PDK1, Pyruvate dehydrogenase kinase 1; HSP, heat shock protein; eNOS, endothelial nitric oxide synthase;
mTOR, mammalian target of rapamycin; 4EBP1, 4E-binding protein 1; ND, nondiabetic; DM, diabetic.
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Mhave shown that the diabetic heart is actually less sensitive to
ischemic injury, especially in in vivo models. Chen and as-
sociates12 showed that type I diabetic rat hearts demon-
strated enhanced tolerance to I–R that was abolished by
preoperative treatment with insulin. Ma and colleagues13
found that capillary density and the expression of cardiopro-
tective proteins, including vascular endothelial growth
factor, eNOS, and phospho-Akt, were increased in rats ex-
posed to 2 weeks of diabetes compared with nondiabetic
rats, whereas infarct size and caspase-3, a proapoptotic
signal, were decreased.
Diabetic Swine
Our DM swine achieved fasting blood glucose levels
nearly 9 times that of ND swine, demonstrating successful1350 The Journal of Thoracic and Cardiovascular Surinduction of type 1 diabetes with alloxan. The mean fasting
blood glucose level in our ND swine of 37 mg/dL was sim-
ilar to previously reported values for nondiabetic Yucatan
swine (43 mg/dL).14
Diabetes decreases infarct size and improves regional
function. The most striking finding in this study was the
significant decrease in infarct size seen in DM compared
with ND animals. A possible explanation lies in the regula-
tion of myocardial glucose uptake during cardiac stress. Un-
der resting conditions, metabolism of fatty acids yields 60%
to 70% of the adenosine triphosphate requirement of the
heart, but during situations of stress the energy preference
shifts to favor use of glucose, diminishing the release of
damaging free radicals by fatty acid oxidation.15 It was
thought that, in the insulin-deficient environment of type Igery c December 2010
FIGURE 5. Selected mitogen activated protein kinase immunoblotting results. Ratio of phospho-Erk to total Erk (A), phospho-p90RSK (B), and SAPK/JNK
(C) expression was assessed in the ischemic and nonischemic territories of ND (n¼ 8) and DM (n¼ 8) animals. Representative bands are shown, with density
expressed as arbitrary units. Data presented as mean  SEM in arbitrary units (AU). *P< .05. Erk, Extracellularly regulated kinase; SAPK/JNK, stress-
activated protein kinase/c-Jun NH2-terminal kinase; ND, nondiabetic; DM, diabetic.
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Mdiabetes, impaired glucose uptake led to less efficient
myocardial metabolism under ischemic conditions. How-
ever, recent studies have uncovered alternative pathways
that may take over glucose regulation during situations of
stress. Adenosine monophosphate–activated protein kinase
(AMPK) has been shown to be an important effector of gly-
colysis and glucose uptake during cellular stress. In the myo-
cardium, AMPK promotes the translocation of glucose
transporter 4 to the cell membrane, increasing myocardial
glucose uptake and protecting the heart from ischemia.16
Hypoxia-induced factor-1a has also been found to play
a role in glucose metabolism under stress, increasing expres-
sion of glucose transporter 1 and enzymes involved in gly-
colysis.17 Hyperglycemic, insulin-deficient animals likely
use these noninsulin–dependent pathways to more effi-
ciently metabolize glucose, thus decreasing ischemic dam-
age. The improvement in horizontal contractility seen in
the AAR of our DM hearts could be due to this increased
availability of metabolic substrate for myocardial contrac-
tion. It should be noted that blood flow through the LAD
during reperfusion was lower in the DM group, which could
mean decreased delivery of inflammatory mediators and free
radicals and decreased reperfusion injury. This difference
between groups is one limitation of the current study, it
but does not explain our Western blotting results.
Diabetic hearts display worsened global function. Mean
arterial pressure, developed LV pressure, and dP/dt were all
lower in DM animals, reflecting worsened global LV func-
tion compared with ND animals. Chronic diabetes, through
a variety of mechanisms including the accumulation of gly-
colytic intermediates, the production of toxic intermediates
from free fatty acid metabolism, and increased myocardial
fibrosis, leads to cellular, structural, and functional changes
in the myocardium termed diabetic cardiomyopathy.18 In
contrast to the AAR, where myocardial stress leads to
increased glucose use, the nonischemic diabetic LV mayThe Journal of Thoracic and Carpreferentially metabolize fatty acids, leading to increased
oxidative stress and worsened global LV function.
Glycogen stores in AAR are increased in diabetic hearts.
Glycogen staining of myocardium from the AAR revealed
a higher amount of glycogen in DM animals compared
with ND animals after I–R. This finding could be interpreted
as either decreased use or increased availability of glycogen,
but given our finding of decreased infarct size in the DM
group, the latter scenario is more likely. Previous studies
have demonstrated that diabetic myocardium contains
more glycogen than nondiabetic myocardium at baseline.19
During situations of stress, when glucose is the preferred
metabolite, the excess glycogen in ischemic diabetic myo-
cardium could fuel cardioprotective mechanisms, whereas
the glycogen supply in ischemic nondiabetic myocardium
is exhausted.
Increased expression of cell survival proteins in diabetic
hearts. In nonischemic myocardium, the expression of sev-
eral proteins involved in cell survival were either similar or
lower in DM animals compared with controls. Interestingly,
the expression of most of these same proteins in the ischemic
area was significantly higher in the DM group compared
with the control group, indicating that cell survival pathways
in ischemic myocardium were more active in these animals.
Akt, PDK1, and eNOS have been shown to reduce adeno-
sine triphosphate breakdown and mitochondrial Caþloading,
ultimately preconditioning the myocardium against I–R in-
jury.7 HSP27 has been shown to protect against I–R injury
via stabilization of troponin I and T20, and HSP70 has
been found to play a role in late ischemic preconditioning
as well.21 Phosphorylation and activation of NF-kB is linked
with cell survival and inflammation.22
Expression of mTOR, phospho-mTOR, phospho-4EBP1,
and p70S6K, a kinase intermediate in the mTOR pathway,
was also higher in the ischemic area of DM animals com-
pared with controls. The glucose-dependent mTOR pathwaydiovascular Surgery c Volume 140, Number 6 1351
Perioperative Management Chu et al
P
Mis critical to protein translation, and inhibition of mTOR
by rapamycin has been shown to block the protective effects
of preconditioning.23 The increased glucose in DM animals
likely means more available substrate for glucose-dependent
mechanisms such as the mTOR pathway.
The same trend was seen when looking at the expression
of mitogen-activated proteins involved in cell growth and
survival. Erk 1/2, its downstream kinase p90RSK,24 and
SAPK/JNK25 have all been associated with preconditioning
and cardioprotection from I–R injury. It is evident that a host
of cell survival proteins and cell growth–related proteins are
upregulated in the ischemic area of diabetic animals.
Duration of hyperglycemia. Several studies in small ani-
mal models have found that streptozotocin-induced diabetes
exerts contradictory effects on myocardial ischemia in
chronic versus acute hyperglycemia, reporting increased in-
farct size and worsened myocardial function in animals with
long-standing disease.14 It is also widely known that long-
term diabetes increases the incidence and complications of
myocardial infarction and can progress to diabetic cardio-
myopathy. A limitation of the current study is that it exam-
ines the effects of hyperglycemia at only 1 time point,
relatively early in the course of diabetes (5 weeks). It is
likely that, as the disease progresses, the other previously
mentioned biological sequelae of hyperglycemia result in
decreased resistance against acute ischemia.
CONCLUSIONS
Recently, government agencies such as the National Insti-
tutes of Health and the Food and Drug Administration have
been putting greater emphasis on clinically relevant large an-
imal models for preclinical experiments. This is due to the
fact that although rodent models of I–R injury and other ex-
periments may give a wealth of information, the findings of-
ten do not translate well to patients.
This study provides evidence that type 1 diabetes mellitus
and resultant hyperglycemia, though detrimental to global
cardiac function and associated with poorer prognosis, are
actually cardioprotective against myocardial I–R injury in
the short term. This is likely a result of increased availability
and use of glucose, the heart’s preferred energy substrate in
times of stress. Thus, the current clinical practice of tightly
controlling blood glucose in patients having cardiac events
may be detrimental to the heart in the acute setting. Recent
investigation into AMPK and hypoxia-induced factor-1a,
potent regulators of glucose uptake in the myocardium, pro-
vides possible mechanisms for the cardioprotective proper-
ties of hyperglycemia. Additional studies using this model
to assess the activity of these enzymes and their targets
would help to further elucidate the pathway and possibly de-
velop therapeutic modalities for protection against ischemia.
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